Necroptosis-Mediated eCIRP Release in Sepsis
Bridgette Reilly,Chuyi Tan,Atsushi Murao,Colleen Nofi,Alok Jha,Monowar Aziz,Ping Wang
DOI: https://doi.org/10.2147/JIR.S370615
IF: 4.5
2022-07-16
Journal of Inflammation Research
Abstract:Bridgette Reilly, 1 Chuyi Tan, 1 Atsushi Murao, 1 Colleen Nofi, 1, 2 Alok Jha, 1 Monowar Aziz, 1– 3 Ping Wang 1– 3 1 Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, NY, USA; 2 Department of Surgery, Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA; 3 Department of Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA Correspondence: Ping Wang; Monowar Aziz, The Feinstein Institutes for Medical Research, 350 Community Dr., Manhasset, NY, 11030, USA, Tel +1 516 562-3411; +1 516 562-2436, Fax +1 516 562-2396, Email ; Introduction: Extracellular cold-inducible RNA-binding protein (eCIRP) is an endogenous pro-inflammatory mediator that exacerbates injury in inflammation and sepsis. The mechanisms in which eCIRP is released have yet to be fully explored. Necroptosis is a programmed cell death that is dependent on the activation of mixed lineage kinase domain-like pseudo kinase (MLKL) which causes the release of damage-associated molecular patterns. We hypothesize that eCIRP is released through necroptosis and intensifies inflammation in sepsis. Methods: RAW264.7 cells were treated with pan-caspase inhibitor z-VAD (15 μM) 1 h before stimulation with LPS (1 μg/mL). Necroptosis inhibitor, Necrostatin-1 (Nec-1) (10 μM) was added to the cells with LPS simultaneously. After 24 h of LPS stimulation, cytotoxicity was determined by LDH assay. eCIRP levels in the culture supernatants and phospho-MLKL (p-MLKL) from cell lysates were assessed by Western blot. p-MLKL interaction with the cell membrane was visualized by immunofluorescence. Sepsis was induced in C57BL/6 mice by cecal ligation and puncture (CLP). Mice were treated with Nec-1 (1 mg/kg) or DMSO. 20 h post-surgery, serum and peritoneal fluid levels of eCIRP, TNF-α and IL-6 were determined by ELISA. H&E staining of lung tissue sections was performed. Results: We found that in RAW264.7 cells, LPS+z-VAD induces necroptosis as evidenced by an increase in p-MLKL levels and causes eCIRP release. Nec-1 reduces both p-MLKL activation and eCIRP release in LPS+z-VAD-treated RAW264.7 cells. Nec-1 also inhibits the release of eCIRP, TNF-α and IL-6 in the serum and peritoneal fluid in CLP-induced septic mice. We predicted a transient interaction between eCIRP and MLKL using a computational model, suggesting that eCIRP may exit the cell via the pores formed by p-MLKL. Conclusion: Necroptosis is a novel mechanism of eCIRP release in sepsis. Targeting necroptosis may ameliorate inflammation and injury in sepsis by inhibiting eCIRP release. Keywords: eCIRP, necroptosis, Necrostatin-1, macrophage, sepsis During sepsis, systemic inflammation can be initiated by pathogen-associated molecular patterns (PAMPs) and damaged-associated molecular patterns (DAMPs). 1 These molecules are recognized by pattern-recognition receptors (PPRs) expressed in both immune and non-immune cells. 1,2 The interaction of PAMPs and DAMPs with PRRs activates several downstream pathways which promote the release of pro-inflammatory mediators such as cytokines and chemokines. Several DAMPs, including extracellular cold-inducible RNA-binding protein (eCIRP), have been classified as alarmin danger signals which trigger inflammatory responses in sepsis. 3 Cold-inducible RNA-binding protein (CIRP) is a glycine-rich RNA chaperone which, under normal conditions, is located in the nucleus and functions to facilitate RNA translation. 4 Under stressed conditions such as hypothermia and hypoxia, CIRP can migrate from the nucleus to cytoplasm and is then released to the extracellular space. 5 Once released extracellularly, eCIRP serves as an endogenous pro-inflammatory mediator and is implicated in exacerbated injury in inflammatory conditions, such as sepsis. 3 Pharmacological inhibition and genetic knockdown of CIRP have been reported to ameliorate organ injury in sepsis 3 as well as other inflammatory conditions. 6–8 eCIRP has been shown to induce inflammatory responses in macrophages, 9 neutrophils, 10 lymphocytes, 11 and endothelial cells. 5 However, the mechanisms by which eCIRP is released from cells have yet to be fully elucidated. Several studies implicate cell death as an active event to trigger or amplify the inflammatory response. 12 Previously, it was assumed that necrosis was distinct from apoptosis, in part owing to the lack of molecular programming in the process of necrosis. However, in recent years it has become clear that necrotic cell death can be driven by distinct molecular p -Abstract Truncated-
immunology